Sushama R. Chaphalkar

Gut microbiota's influence on circadian rhythms may hold the key to understanding how stress responses vary throughout the day, potentially offering new insights for treating stress-related disorders.

Despite assumptions about education's positive influence on brain structure, new findings suggest that even an additional year of schooling doesn't leave a lasting neural footprint.

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment through advanced 3D modeling techniques.

Research shows mitochondria form distinct subpopulations under nutrient stress, revealing survival mechanisms in cancer cells and potential therapeutic targets.

With MassiveFold, scientists have unlocked AlphaFold's full potential, making high-confidence protein predictions faster and more accessible, fueling breakthroughs in biology and drug discovery.

By combining advanced gene editing techniques, scientists identified key mutations that influence tumor growth and drug resistance in lung cancer, offering new avenues for tailored cancer therapies.

A long-term study reveals how tirzepatide not only cuts weight but also slashes diabetes risk in people with prediabetes, highlighting a major advance in obesity and diabetes care.

Harnessing AI agents and human expertise, researchers accelerate the design of innovative nanobodies to combat evolving SARS-CoV-2 variants.

Harnessing synthetic biology, researchers unveil SNIPRs—receptors that revolutionize CAR T-cell therapies by enhancing tumor precision and safety.

Researchers unveil a groundbreaking DNA vaccine that supercharges immunity and boosts survival in patients with aggressive breast cancer—could this be the future of personalized cancer treatment?